Stockreport

SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

SIGA Technologies Inc.  (SIGA) 
US:NASDAQ Investor Relations: investor.siga.com/investor-relations
PDF NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, [Read more]